David M. Markovitz - Publications

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Immunology, Microbiology Biology

99 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Saha AK, Mourad M, Kaplan MH, Chefetz I, Malek SN, Buckanovich R, Markovitz DM, Contreras-Galindo R. The Genomic Landscape of Centromeres in Cancers. Scientific Reports. 9: 11259. PMID 31375789 DOI: 10.1038/s41598-019-47757-6  0.32
2019 Covés-Datson EM, Dyall J, DeWald LE, King SR, Dube D, Legendre M, Nelson E, Drews KC, Gross R, Gerhardt DM, Torzewski L, Postnikova E, Liang JY, Ban B, Shetty J, ... ... Markovitz DM, et al. Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin. Plos Neglected Tropical Diseases. 13: e0007595. PMID 31356611 DOI: 10.1371/journal.pntd.0007595  0.32
2019 Capitano ML, Mor-Vaknin N, Saha AK, Cooper S, Legendre M, Guo H, Contreras-Galindo R, Kappes F, Sartor MA, Lee CT, Huang X, Markovitz DM, Broxmeyer HE. Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling. The Journal of Clinical Investigation. 130. PMID 31107242 DOI: 10.1172/JCI127460  0.52
2019 Chan SM, Sapir T, Park SS, Rual JF, Contreras-Galindo R, Reiner O, Markovitz DM. The HERV-K accessory protein Np9 controls viability and migration of teratocarcinoma cells. Plos One. 14: e0212970. PMID 30818388 DOI: 10.1371/journal.pone.0212970  0.32
2018 Ghosh P, Halvorsen EM, Ammendolia DA, Mor-Vaknin N, O'Riordan MXD, Brumell JH, Markovitz DM, Higgins DE. Invasion of the Brain byIs Mediated by InlF and Host Cell Vimentin. Mbio. 9. PMID 29487235 DOI: 10.1128/mBio.00160-18  0.52
2017 Mor-Vaknin N, Rivas M, Legendre M, Mohan S, Yuanfan Y, Mau T, Johnson A, Huang B, Zhao L, Kimura Y, Spalding SJ, Morris PW, Gottlieb BS, Onel K, Olson JC, ... ... Markovitz DM, et al. High levels of DEK autoantibodies in sera of polyarticular JIA patients and in early flare following cessation of anti-TNF therapy. Arthritis & Rheumatology (Hoboken, N.J.). PMID 29287303 DOI: 10.1002/art.40404  0.52
2017 Contreras-Galindo R, Fischer S, Saha AK, Lundy JD, Cervantes PW, Mourad M, Wang C, Qian B, Dai M, Meng F, Chinnaiyan A, Omenn GS, Kaplan MH, Markovitz DM. Rapid molecular assays to study human centromere genomics. Genome Research. PMID 29141960 DOI: 10.1101/gr.219709.116  0.32
2017 Contreras-Galindo RA, Dube D, Fujinaga K, Kaplan MH, Markovitz DM. Susceptibility of Human Endogenous Retrovirus Type-K to Reverse Transcriptase Inhibitors. Journal of Virology. PMID 28931682 DOI: 10.1128/JVI.01309-17  0.32
2017 Mor-Vaknin N, Saha A, Legendre M, Carmona-Rivera C, Amin MA, Rabquer BJ, Gonzales-Hernandez MJ, Jorns J, Mohan S, Yalavarthi S, Pai DA, Angevine K, Almburg SJ, Knight JS, Adams BS, ... ... Markovitz DM, et al. DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis. Nature Communications. 8: 14252. PMID 28165452 DOI: 10.1038/ncomms14252  0.52
2016 Xiao Q, Wang Z, Williams D, Leowanawat P, Peterca M, Sherman SE, Zhang S, Hammer DA, Heiney PA, King SR, Markovitz DM, André S, Gabius HJ, Klein ML, Percec V. Why Do Membranes of Some Unhealthy Cells Adopt a Cubic Architecture? Acs Central Science. 2: 943-953. PMID 28058284 DOI: 10.1021/acscentsci.6b00284  0.32
2016 Huang SH, Chi F, Peng L, Bo T, Zhang B, Liu LQ, Wu X, Mor-Vaknin N, Markovitz DM, Cao H, Zhou YH. Vimentin, a Novel NF-κB Regulator, Is Required for Meningitic Escherichia coli K1-Induced Pathogen Invasion and PMN Transmigration across the Blood-Brain Barrier. Plos One. 11: e0162641. PMID 27657497 DOI: 10.1371/journal.pone.0162641  0.52
2016 Russo BC, Stamm LM, Raaben M, Kim CM, Kahoud E, Robinson LR, Bose S, Queiroz AL, Herrera BB, Baxt LA, Mor-Vaknin N, Fu Y, Molina G, Markovitz DM, Whelan SP, et al. Intermediate filaments enable pathogen docking to trigger type 3 effector translocation. Nature Microbiology. 1: 16025. PMID 27572444 DOI: 10.1038/nmicrobiol.2016.25  0.52
2015 Swanson MD, Boudreaux DM, Salmon L, Chugh J, Winter HC, Meagher JL, André S, Murphy PV, Oscarson S, Roy R, King S, Kaplan MH, Goldstein IJ, Tarbet EB, Hurst BL, ... ... Markovitz DM, et al. Engineering a Therapeutic Lectin by Uncoupling Mitogenicity from Antiviral Activity. Cell. 163: 746-58. PMID 26496612 DOI: 10.1016/j.cell.2015.09.056  0.4
2015 Contreras-Galindo R, Kaplan MH, Dube D, Gonzalez-Hernandez MJ, Chan S, Meng F, Dai M, Omenn GS, Gitlin SD, Markovitz DM. Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related Sequences. Journal of Virology. 89: 7187-201. PMID 25926654 DOI: 10.1128/JVI.00544-15  0.72
2015 Zahn J, Kaplan MH, Fischer S, Dai M, Meng F, Saha AK, Cervantes P, Chan SM, Dube D, Omenn GS, Markovitz DM, Contreras-Galindo R. Expansion of a novel endogenous retrovirus throughout the pericentromeres of modern humans. Genome Biology. 16: 74. PMID 25886262 DOI: 10.1186/s13059-015-0641-1  0.72
2015 Logan GE, Mor-Vaknin N, Braunschweig T, Jost E, Schmidt PV, Markovitz DM, Mills KI, Kappes F, Percy MJ. DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML). Blood Cells, Molecules & Diseases. 54: 123-31. PMID 25128083 DOI: 10.1016/j.bcmd.2014.07.009  0.72
2014 Dube D, Contreras-Galindo R, He S, King SR, Gonzalez-Hernandez MJ, Gitlin SD, Kaplan MH, Markovitz DM. Genomic flexibility of human endogenous retrovirus type K. Journal of Virology. 88: 9673-82. PMID 24920813 DOI: 10.1128/JVI.01147-14  0.72
2014 Gonzalez-Hernandez MJ, Cavalcoli JD, Sartor MA, Contreras-Galindo R, Meng F, Dai M, Dube D, Saha AK, Gitlin SD, Omenn GS, Kaplan MH, Markovitz DM. Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein. Journal of Virology. 88: 8924-35. PMID 24872592 DOI: 10.1128/JVI.00556-14  0.72
2013 Broxmeyer HE, Mor-Vaknin N, Kappes F, Legendre M, Saha AK, Ou X, O'Leary H, Capitano M, Cooper S, Markovitz DM. Concise review: role of DEK in stem/progenitor cell biology. Stem Cells (Dayton, Ohio). 31: 1447-53. PMID 23733396 DOI: 10.1002/stem.1443  0.72
2013 Contreras-Galindo R, Kaplan MH, He S, Contreras-Galindo AC, Gonzalez-Hernandez MJ, Kappes F, Dube D, Chan SM, Robinson D, Meng F, Dai M, Gitlin SD, Chinnaiyan AM, Omenn GS, Markovitz DM. HIV infection reveals widespread expansion of novel centromeric human endogenous retroviruses. Genome Research. 23: 1505-13. PMID 23657884 DOI: 10.1101/gr.144303.112  0.72
2013 Saha AK, Kappes F, Mundade A, Deutzmann A, Rosmarin DM, Legendre M, Chatain N, Al-Obaidi Z, Adams BS, Ploegh HL, Ferrando-May E, Mor-Vaknin N, Markovitz DM. Intercellular trafficking of the nuclear oncoprotein DEK. Proceedings of the National Academy of Sciences of the United States of America. 110: 6847-52. PMID 23569252 DOI: 10.1073/pnas.1220751110  0.72
2013 Mor-Vaknin N, Legendre M, Yu Y, Serezani CH, Garg SK, Jatzek A, Swanson MD, Gonzalez-Hernandez MJ, Teitz-Tennenbaum S, Punturieri A, Engleberg NC, Banerjee R, Peters-Golden M, Kao JY, Markovitz DM. Murine colitis is mediated by vimentin. Scientific Reports. 3: 1045. PMID 23304436 DOI: 10.1038/srep01045  0.72
2012 Monde K, Contreras-Galindo R, Kaplan MH, Markovitz DM, Ono A. Human endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1. Journal of Virology. 86: 11194-208. PMID 22855497 DOI: 10.1128/JVI.00301-12  0.72
2012 Patel RM, Walters LL, Kappes F, Mehra R, Fullen DR, Markovitz DM, Ma L. DEK expression in Merkel cell carcinoma and small cell carcinoma. Journal of Cutaneous Pathology. 39: 753-7. PMID 22765016 DOI: 10.1111/j.1600-0560.2012.01941.x  0.72
2012 Férir G, Huskens D, Palmer KE, Boudreaux DM, Swanson MD, Markovitz DM, Balzarini J, Schols D. Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV Type 1, HIV Type 2, and selected carbohydrate-binding agent-resistant HIV Type 1 strains. Aids Research and Human Retroviruses. 28: 1513-23. PMID 22607556 DOI: 10.1089/AID.2012.0026  0.72
2012 Gonzalez-Hernandez MJ, Swanson MD, Contreras-Galindo R, Cookinham S, King SR, Noel RJ, Kaplan MH, Markovitz DM. Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1. Journal of Virology. 86: 7790-805. PMID 22593154 DOI: 10.1128/JVI.07215-11  0.72
2012 Contreras-Galindo R, Kaplan MH, Contreras-Galindo AC, Gonzalez-Hernandez MJ, Ferlenghi I, Giusti F, Lorenzo E, Gitlin SD, Dosik MH, Yamamura Y, Markovitz DM. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals. Journal of Virology. 86: 262-76. PMID 22031938 DOI: 10.1128/JVI.00602-11  0.72
2012 Broxmeyer HE, Kappes F, Mor-Vaknin N, Legendre M, Kinzfogl J, Cooper S, Hangoc G, Markovitz DM. DEK regulates hematopoietic stem engraftment and progenitor cell proliferation. Stem Cells and Development. 21: 1449-54. PMID 21943234 DOI: 10.1089/scd.2011.0451  0.72
2011 Stelzer AC, Frank AT, Kratz JD, Swanson MD, Gonzalez-Hernandez MJ, Lee J, Andricioaei I, Markovitz DM, Al-Hashimi HM. Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble. Nature Chemical Biology. 7: 553-9. PMID 21706033 DOI: 10.1038/nchembio.596  0.72
2011 Férir G, Vermeire K, Huskens D, Balzarini J, Van Damme EJ, Kehr JC, Dittmann E, Swanson MD, Markovitz DM, Schols D. Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs). Antiviral Research. 90: 200-4. PMID 21501631 DOI: 10.1016/j.antiviral.2011.03.188  0.72
2011 Kappes F, Waldmann T, Mathew V, Yu J, Zhang L, Khodadoust MS, Chinnaiyan AM, Luger K, Erhardt S, Schneider R, Markovitz DM. The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity. Genes & Development. 25: 673-8. PMID 21460035 DOI: 10.1101/gad.2036411  0.72
2011 Kappes F, Khodadoust MS, Yu L, Kim DS, Fullen DR, Markovitz DM, Ma L. DEK expression in melanocytic lesions. Human Pathology. 42: 932-8. PMID 21316078 DOI: 10.1016/j.humpath.2010.10.022  0.72
2011 Mor-Vaknin N, Kappes F, Dick AE, Legendre M, Damoc C, Teitz-Tennenbaum S, Kwok R, Ferrando-May E, Adams BS, Markovitz DM. DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen. Arthritis and Rheumatism. 63: 556-67. PMID 21280010 DOI: 10.1002/art.30138  0.72
2010 Dai M, Thompson RC, Maher C, Contreras-Galindo R, Kaplan MH, Markovitz DM, Omenn G, Meng F. NGSQC: cross-platform quality analysis pipeline for deep sequencing data. Bmc Genomics. 11: S7. PMID 21143816 DOI: 10.1186/1471-2164-11-S4-S7  0.72
2010 Fahrer J, Popp O, Malanga M, Beneke S, Markovitz DM, Ferrando-May E, Bürkle A, Kappes F. High-affinity interaction of poly(ADP-ribose) and the human DEK oncoprotein depends upon chain length. Biochemistry. 49: 7119-30. PMID 20669926 DOI: 10.1021/bi1004365  0.72
2010 Swanson MD, Winter HC, Goldstein IJ, Markovitz DM. A lectin isolated from bananas is a potent inhibitor of HIV replication. The Journal of Biological Chemistry. 285: 8646-55. PMID 20080975 DOI: 10.1074/jbc.M109.034926  0.72
2010 McDowell KL, Begley LA, Mor-Vaknin N, Markovitz DM, Macoska JA. Leukocytic promotion of prostate cellular proliferation. The Prostate. 70: 377-89. PMID 19866464 DOI: 10.1002/pros.21071  0.72
2009 Khodadoust MS, Verhaegen M, Kappes F, Riveiro-Falkenbach E, Cigudosa JC, Kim DS, Chinnaiyan AM, Markovitz DM, Soengas MS. Melanoma proliferation and chemoresistance controlled by the DEK oncogene. Cancer Research. 69: 6405-13. PMID 19679545 DOI: 10.1158/0008-5472.CAN-09-1063  0.72
2008 Contreras-Galindo R, Kaplan MH, Leissner P, Verjat T, Ferlenghi I, Bagnoli F, Giusti F, Dosik MH, Hayes DF, Gitlin SD, Markovitz DM. Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. Journal of Virology. 82: 9329-36. PMID 18632860 DOI: 10.1128/JVI.00646-08  0.72
2008 Kappes F, Fahrer J, Khodadoust MS, Tabbert A, Strasser C, Mor-Vaknin N, Moreno-Villanueva M, Bürkle A, Markovitz DM, Ferrando-May E. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress. Molecular and Cellular Biology. 28: 3245-57. PMID 18332104 DOI: 10.1128/MCB.01921-07  0.72
2008 Bielinska AU, Janczak KW, Landers JJ, Markovitz DM, Montefiori DC, Baker JR. Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates. Aids Research and Human Retroviruses. 24: 271-81. PMID 18260780 DOI: 10.1089/aid.2007.0148  0.72
2008 Devany M, Kappes F, Chen KM, Markovitz DM, Matsuo H. Solution NMR structure of the N-terminal domain of the human DEK protein. Protein Science : a Publication of the Protein Society. 17: 205-15. PMID 18227428 DOI: 10.1110/ps.073244108  0.72
2007 Bargagna-Mohan P, Hamza A, Kim YE, Khuan Abby Ho Y, Mor-Vaknin N, Wendschlag N, Liu J, Evans RM, Markovitz DM, Zhan CG, Kim KB, Mohan R. The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin. Chemistry & Biology. 14: 623-34. PMID 17584610 DOI: 10.1016/j.chembiol.2007.04.010  0.72
2006 Contreras-Galindo R, Kaplan MH, Markovitz DM, Lorenzo E, Yamamura Y. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals. Aids Research and Human Retroviruses. 22: 979-84. PMID 17067267 DOI: 10.1089/aid.2006.22.979  0.72
2006 Mor-Vaknin N, Punturieri A, Sitwala K, Faulkner N, Legendre M, Khodadoust MS, Kappes F, Ruth JH, Koch A, Glass D, Petruzzelli L, Adams BS, Markovitz DM. The DEK nuclear autoantigen is a secreted chemotactic factor. Molecular and Cellular Biology. 26: 9484-96. PMID 17030615 DOI: 10.1128/MCB.01030-06  0.72
2006 Malani PN, Read J, Rees RS, Markovitz DM. Beyond antimicrobials: A review of adjunctive therapies for pressure ulcers in older adults Infectious Diseases in Clinical Practice. 14: 345-349. DOI: 10.1097/01.idc.0000239718.24713.77  0.72
2005 Cleary J, Sitwala KV, Khodadoust MS, Kwok RP, Mor-Vaknin N, Cebrat M, Cole PA, Markovitz DM. p300/CBP-associated factor drives DEK into interchromatin granule clusters. The Journal of Biological Chemistry. 280: 31760-7. PMID 15987677 DOI: 10.1074/jbc.M500884200  0.72
2004 Xu B, deWaal RM, Mor-Vaknin N, Hibbard C, Markovitz DM, Kahn ML. The endothelial cell-specific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature. Molecular and Cellular Biology. 24: 9198-206. PMID 15456890 DOI: 10.1128/MCB.24.20.9198-9206.2004  0.72
2003 Sitwala KV, Mor-Vaknin N, Markovitz DM. Minireview: DEK and gene regulation, oncogenesis and AIDS. Anticancer Research. 23: 2155-8. PMID 12894590  0.72
2003 Adams BS, Cha HC, Cleary J, Haiying T, Wang H, Sitwala K, Markovitz DM. DEK binding to class II MHC Y-box sequences is gene- and allele-specific. Arthritis Research & Therapy. 5: R226-33. PMID 12823858 DOI: 10.1186/ar774  0.72
2003 Lane BR, King SR, Bock PJ, Strieter RM, Coffey MJ, Markovitz DM. The C-X-C chemokine IP-10 stimulates HIV-1 replication. Virology. 307: 122-34. PMID 12667820 DOI: 10.1016/S0042-6822(02)00045-4  0.72
2003 Faulkner NE, Lane BR, Bock PJ, Markovitz DM. Protein phosphatase 2A enhances activation of human immunodeficiency virus type 1 by phorbol myristate acetate. Journal of Virology. 77: 2276-81. PMID 12525665 DOI: 10.1128/JVI.77.3.2276-2281.2003  0.72
2003 Mor-Vaknin N, Punturieri A, Sitwala K, Markovitz DM. Vimentin is secreted by activated macrophages. Nature Cell Biology. 5: 59-63. PMID 12483219 DOI: 10.1038/ncb898  0.72
2002 Sitwala KV, Adams K, Markovitz DM. YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter. Oncogene. 21: 8862-70. PMID 12483538 DOI: 10.1038/sj.onc.1206041  0.72
2002 Lane BR, Liu J, Bock PJ, Schols D, Coffey MJ, Strieter RM, Polverini PJ, Markovitz DM. Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma. Journal of Virology. 76: 11570-83. PMID 12388718 DOI: 10.1128/JVI.76.22.11570-11583.2002  0.72
2002 Hayes MM, Lane BR, King SR, Markovitz DM, Coffey MJ. Prostaglandin E(2) inhibits replication of HIV-1 in macrophages through activation of protein kinase A. Cellular Immunology. 215: 61-71. PMID 12142037 DOI: 10.1016/S0008-8749(02)00017-5  0.72
2002 Labarca JA, Gaete PA, Gutiérrez M, Pérez CM, Markovitz DM, Gitlin SD, Ofotokun I. Thrombosis, vasculitis, and cytomegalovirus infection [2] (multiple letters) Clinical Infectious Diseases. 34: 1658-1660. PMID 12032908 DOI: 10.1086/340715  0.72
2002 Hayes MM, Lane BR, King SR, Markovitz DM, Coffey MJ. Peroxisome proliferator-activated receptor gamma agonists inhibit HIV-1 replication in macrophages by transcriptional and post-transcriptional effects. The Journal of Biological Chemistry. 277: 16913-9. PMID 11847231 DOI: 10.1074/jbc.M200875200  0.72
2001 Bock PJ, Markovitz DM. Infection with hiv-2 Aids. 15. PMID 11816173 DOI: 10.1097/00002030-200102001-00052  0.72
2001 Lane BR, Lore K, Bock PJ, Andersson J, Coffey MJ, Strieter RM, Markovitz DM. Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. Journal of Virology. 75: 8195-202. PMID 11483765 DOI: 10.1128/JVI.75.17.8195-8202.2001  0.72
2001 Lane BR, Strieter RM, Coffey MJ, Markovitz DM. Human immunodeficiency virus type 1 (HIV-1)-induced GRO-alpha production stimulates HIV-1 replication in macrophages and T lymphocytes. Journal of Virology. 75: 5812-22. PMID 11390582 DOI: 10.1128/JVI.75.13.5812-5822.2001  0.72
2001 Faulkner NE, Hilfinger JM, Markovitz DM. Protein phosphatase 2A activates the HIV-2 promoter through enhancer elements that include the pets site. The Journal of Biological Chemistry. 276: 25804-12. PMID 11320078 DOI: 10.1074/jbc.M006454200  0.72
2001 Ofotokun I, Carlson C, Gitlin SD, Elta G, Singleton TP, Markovitz DM. Acute cytomegalovirus infection complicated by vascular thrombosis: a case report. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 32: 983-6. PMID 11247723 DOI: 10.1086/319353  0.72
2001 Browning CM, Smith MJ, Clark NM, Lane BR, Parada C, Montano M, KewalRamani VN, Littman DR, Essex M, Roeder RG, Markovitz DM. Human GLI-2 is a tat activation response element-independent Tat cofactor. Journal of Virology. 75: 2314-23. PMID 11160734 DOI: 10.1128/JVI.75.5.2314-2323.2001  0.72
2001 Smith MJ, Gitlin SD, Browning CM, Lane BR, Clark NM, Shah N, Rainier S, Markovitz DM. GLI-2 modulates retroviral gene expression. Journal of Virology. 75: 2301-13. PMID 11160733 DOI: 10.1128/JVI.75.5.2301-2313.2001  0.72
1999 Lane BR, Markovitz DM, Woodford NL, Rochford R, Strieter RM, Coffey MJ. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. Journal of Immunology (Baltimore, Md. : 1950). 163: 3653-61. PMID 10490959  0.72
1999 Browning CM, Cagnon L, Good PD, Rossi J, Engelke DR, Markovitz DM. Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 Tat activation-response RNA decoy Journal of Virology. 73: 5191-5195. PMID 10233987  0.72
1998 Clark NM, Dieng Sarr A, Sankale JL, Kanki PJ, Kazanjian P, Winfield R, Markovitz DM. Immunologic and virologic response of HIV-2 infection to antiretroviral therapy [5] Aids. 12: 2506-2507. PMID 9875594  0.72
1998 Geisler WM, Markovitz DM. Septic arthritis caused by Neisseria sicca The Journal of Rheumatology. 25: 826-828. PMID 9558202  0.72
1998 Fu GK, Markovitz DM. The human LON protease binds to mitochondrial promoters in a single- stranded, site-specific, strand-specific manner Biochemistry. 37: 1905-1909. PMID 9485316 DOI: 10.1021/bi970928c  0.72
1997 Browning C, Hilfinger JM, Rainier S, Lin V, Hedderwick S, Smith M, Markovitz DM. The sequence and structure of the 3' arm of the first stem-loop of the human immunodeficiency virus type 2 trans-activation responsive region mediate Tat-2 transactivation Journal of Virology. 71: 8048-8055. PMID 9311903  0.72
1997 Coffey MJ, Woffendin C, Phare SM, Strieter RM, Markovitz DM. RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveolar macrophages. The American Journal of Physiology. 272: L1025-9. PMID 9176270  0.72
1997 Fu GK, Grosveld G, Markovitz DM. DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer Proceedings of the National Academy of Sciences of the United States of America. 94: 1811-1815. PMID 9050861 DOI: 10.1073/pnas.94.5.1811  0.72
1997 Fu GK, Smith MJ, Markovitz DM. Bacterial protease Lon is a site-specific DNA-binding protein Journal of Biological Chemistry. 272: 534-538. PMID 8995294 DOI: 10.1074/jbc.272.1.534  0.72
1996 Fu GK, Markovitz DM. Purification of the pets factor. A nuclear protein that binds to the inducible TG-rich element of the human immunodeficiency virus type 2 enhancer Journal of Biological Chemistry. 271: 19599-19605. PMID 8702655 DOI: 10.1074/jbc.271.32.19599  0.72
1995 Lin VH, Parekh RS, McQuillan MA, Braun DK, Markovitz DM. Meningococcal endocarditis presenting as cellulitis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 21: 1023-5. PMID 8645793 DOI: 10.1093/clinids/21.4.1023  0.72
1995 Whimbey SG, Applegate AL, Markovitz DM. Delirium associated with acyclovir treatment in a patient with renal failure Clinical Infectious Diseases. 21: 435-436. PMID 8562758 DOI: 10.1093/clinids/21.2.435  0.72
1995 Walling DM, Clark NM, Markovitz DM, Frank TS, Braun DK, Eisenberg E, Krutchkoff DJ, Felix DH, Raab-Traub N. Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia. The Journal of Infectious Diseases. 171: 1122-30. PMID 7751686 DOI: 10.1093/infdis/171.5.1122  0.72
1995 Clark NM, Hannibal MC, Markovitz DM. The peri-κB site mediates human immunodeficiency virus type 2 enhancer activation in monocytes but not in T cells Journal of Virology. 69: 4854-4862. PMID 7609053  0.72
1994 Hannibal MC, Markovitz DM, Nabel GJ. Multiple cis-acting elements in the human immunodeficiency virus type 2 enhancer mediate the response to T-cell receptor stimulation by antigen in a T-cell hybridoma line Blood. 83: 1839-1846. PMID 8142652  0.72
1994 Mitchell MA, Markovitz DM, Killen PD, Braun DK. Bilateral renal parenchymal malacoplakia presenting as fever of unknown origin: case report and review Clinical Infectious Diseases. 18: 704-718. PMID 7915547 DOI: 10.1093/clinids/18.5.704  0.72
1993 Hilfinger JM, Clark N, Smith M, Robinson K, Markovitz DM. Differential regulation of the human immunodeficiency virus type 2 enhancer in monocytes at various stages of differentiation Journal of Virology. 67: 4448-4453. PMID 8510231  0.72
1993 Eck SL, Morse JH, Janssen DA, Emerson SG, Markovitz DM. Angioedema presenting as chronic gastrointestinal symptoms American Journal of Gastroenterology. 88: 436-439. PMID 8438855  0.72
1993 Chenoweth CE, Singal S, Pearson RD, Betts RF, Markovitz DM. Acquired immunodeficiency syndrome-related visceral leishmaniasis presenting in a pleural effusion Chest. 103: 648-649. PMID 8432183  0.72
1993 Markovitz DM. Infection with the human immunodeficiency virus type 2 Annals of Internal Medicine. 118: 211-218. PMID 8380244  0.72
1993 Clark NM, Smith MJ, Hilfinger JM, Markovitz DM. Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor Journal of Virology. 67: 5522-5528. PMID 8350410  0.72
1993 Hannibal MC, Markovitz DM, Clark N, Nabel GJ. Differential activation of human immunodeficiency virus type 1 and 2 transcription by specific T-cell activation signals Journal of Virology. 67: 5035-5040. PMID 8331739  0.72
1992 Markovitz DM, Hannibal MC, Smith MJ, Cossman R, Nabel GJ. Activation of the human immunodeficiency virus type 1 enhancer is not dependent on NFAT-1 Journal of Virology. 66: 3961-3965. PMID 1533884  0.72
1992 Leiden JM, Wang CY, Petryniak B, Markovitz DM, Nabel GJ, Thompson CB. A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells. Journal of Virology. 66: 5890-7. PMID 1527846  0.72
1992 Markovitz DM, Smith MJ, Hilfinger J, Hannibal MC, Petryniak B, Nabel GJ. Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and κB regulatory elements Journal of Virology. 66: 5479-5484. PMID 1501284  0.72
1992 Wertheim WA, Markovitz DM. Osteomyelitis and intervertebral discitis caused by Pseudomonas pickettii Journal of Clinical Microbiology. 30: 2506-2508. PMID 1401027  0.72
1990 Markovitz DM, Hannibal M, Perez VL, Gauntt C, Folks TM, Nabel GJ. Differential regulation of human immunodeficiency viruses (HIVs): A specific regulatory element in HIV-2 responds to stimulation of the T-cell antigen receptor Proceedings of the National Academy of Sciences of the United States of America. 87: 9098-9102. PMID 2147512  0.72
1989 Markovitz DM, Kenney S, Kamine J, Smith MS, Davis M, Huang ES, Rosen C, Pagano JS. Disparate effects of two herpesviruses immediate-early gene trans-activators on the HIV-1 LTR Virology. 173: 750-754. PMID 2556854 DOI: 10.1016/0042-6822(89)90591-6  0.72
1987 Hall CB, Dolin R, Gala CL, Markovitz DM, Zhang YQ, Madore PH, Disney FA, Talpey WB, Green JL, Francis AB. Children with influenza A infection: Treatment with rimantadine Pediatrics. 80: 275-282. PMID 3302925  0.72
1986 Markovitz DM, Beutner KR, Maggio RP, Reichman RC. Failure of Recommended Treatment for Secondary Syphilis Jama: the Journal of the American Medical Association. 255: 1767-1768. PMID 3951104 DOI: 10.1001/jama.1986.03370130123036  0.72
1986 Gartner S, Markovits P, Markovitz DM, Betts RF, Popovic M. Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS Journal of the American Medical Association. 256: 2365-2371. PMID 3490587 DOI: 10.1001/jama.256.17.2365  0.72
1986 Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection Science. 233: 215-219. PMID 3014648  0.72
1986 Reichman RC, Markovitz DM. In Reply Jama: the Journal of the American Medical Association. 256: 1443-1444. DOI: 10.1001/jama.1986.03380110049016  0.72
1981 Tack KJ, Bittner MJ, Peterson PK, Rhame FS, Markovitz DM. On Building a Bibliography Jama: the Journal of the American Medical Association. 245: 129. DOI: 10.1001/jama.1981.03310270011014  0.72
Show low-probability matches.